The International Council for Harmonisation has announced the adoption of a harmonization topic that will address factors that must be considered in determining the utility of comparative efficacy studies in biosimilar development programs.
The new ICH Multidisciplinary Guideline was unveiled at a recent meeting in Madrid, but the starting timeframe will be determined...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?